Accordingly, further studies to investigate pH-regulated effectors of p53 in bladder cancer, such as SREBP2, might be needed to predict and prevent UTUC recurrence. The gene discussed is SREBF2; the disease is renal pelvis/ureter urothelial carcinoma.